ImmunityBio (IBRX) Current Deferred Revenue (2014 - 2018)
ImmunityBio (IBRX) reported Current Deferred Revenue of $598000.0 for Q4 2018, up 15.0% year-over-year from $520000.0 in Q4 2017, and up 3.64% quarter-over-quarter from $577000.0 in Q3 2018.
ImmunityBio (IBRX) Current Deferred Revenue (2014 - 2018) Analysis & Trends
ImmunityBio (IBRX) has 5 years of Current Deferred Revenue data on file, last reported at $598000.0 in Q4 2018.
- Current Deferred Revenue for Q4 2018 came in at $598000.0, up 15.0% year-over-year; the trailing twelve-month figure through Dec 2018 was $598000.0 (up 15.0% YoY), and the FY2018 annual result was $598000.0, up 15.0% from the prior year.
- Current Deferred Revenue rose to $598000.0 in Q4 2018 per IBRX's latest filing, from $577000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $598000.0 in Q4 2018 and troughed at $5000.0 in Q4 2015.
- A 5-year average of $407538.5 and a median of $501000.0 in 2017 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2015 and 2016: Current Deferred Revenue plunged 99.04% in 2015, then jumped 3840.0% in 2016.
- A 5-year view of Current Deferred Revenue shows it stood at $521000.0 in 2014, then sank by 99.04% to $5000.0 in 2015, then jumped by 3840.0% to $197000.0 in 2016, then jumped by 163.96% to $520000.0 in 2017, then climbed by 15.0% to $598000.0 in 2018.
- Business Quant data shows IBRX's Current Deferred Revenue at $598000.0 in Q4 2018, $577000.0 in Q3 2018, and $558000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 598,000.00 |
| Sep 30, 2018 | 577,000.00 |
| Jun 30, 2018 | 558,000.00 |
| Mar 31, 2018 | 539,000.00 |
| Dec 31, 2017 | 520,000.00 |
| Sep 30, 2017 | 501,000.00 |
| Jun 30, 2017 | 484,000.00 |
| Mar 31, 2017 | 215,000.00 |
| Dec 31, 2016 | 197,000.00 |
| Dec 31, 2015 | 5,000.00 |
| Sep 30, 2015 | 342,000.00 |
| Jun 30, 2015 | 241,000.00 |
| Dec 31, 2014 | 521,000.00 |